Prevalence of renal artery stenosis in subjects with type 2 diabetes and coexistent hypertension

Diabetes Care

Volumn 23, Issue 4, 2000, Pages 539-543

  Valabhji, Jonathan ^a   Robinson, Stephen ^a   Poulter, Claire ^a   Robinson, Adam C J ^a   Kong, Chantal ^a   Henzen, Christoph ^a   Gedroyc, Wladyslaw M W ^a   Feher, Michael D ^b   Elkeles, Robert S ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; CREATININE;

ADULT; AGED; ARTICLE; CREATININE BLOOD LEVEL; FEMALE; HEMODYNAMICS; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PLASMA RENIN ACTIVITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0034074959     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.23.4.539     Document Type: Article

References (19)

1. Williams GH: Converting-enzyme inhibitors in the treatment of hypertension. N Engl J Med 319:1517-1525, 1988
2. Garg R, Yusuf S: Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure: Collaborative Group on ACE Inhibitor Trials. JAMA 273: 1450-1456, 1995
3. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy: the Collaborative Study Group. N Engl J Med 329:1456-1462, 1993
4. Giordano M, Sanders L, Castellino P, Canessa M, DeFronzo R: Effect of alpha-adrenergic blockers, ACE inhibitors and calcium channel antagonists on renal function in hypertensive non-insulin-dependent diabetic patients. Nephron 72:447-453, 1996
5. Marshall W: Clinical Chemistry. 2nd ed. London, Gower Medical, 1998
6. Kumar A, Asim M, Davison AM: Taking precautions with ACE inhibitors: a theoretical risk exists in patients with unilateral renal artery stenosis. BMJ 316:1921, 1998
7. Gedroyc WMW, Neerhut P, Negus R, Palmer A, Al-Kutoubi A, Taube D, Hulme B: Magnetic resonance angiography of renal artery stenosis. Clin Radiol 50:436-439, 1995
8. MacDowall P, Kalra PA, O Donoghue DJ, Waldek S, Mamtora H, Brown K: Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure. Lancet 352:13-16, 1998
9. Henrich WL: Renal artery disease in the elderly. Geriatr Nephrol Urol 9:81-86, 1999
10. Muller FB, Sealey JE, Case DB, Atlas SA, Pickering TG, Pecker MS, Preibisz JJ, Laragh JH: The captopril test for identifying renovascular disease in hypertensive patients. Am J Med 80:633-644, 1986
11. Frederickson ED, Wilcox CS, Bucci CM, Loon NR, Peterson JC, Brown NL, Thompson RD, Smith TB, Wingo CS: A prospective evaluation of a simplified captopril test for the detection of renovascular hypertension. Arch Intern Med 150:569-572, 1990
12. Sawicki PT, Kaiser S, Heinemann L, Frenzel H, Berger M: Prevalence of renal artery stenosis in diabetes mellitus: an autopsy study. J Intern Med 229:489-492, 1991
13. Ritchie CM, McIlrath E, Hadden DR, Weaver JA, Kennedy L, Atkinson AB: Renal artery stenosis in hypertensive diabetic patients. Diabet Med 5:265-267, 1988
14. Courreges JP, Bacha J, Aboud E: Prevalence and profile of renovascular disease in type II diabetic patients with severe hypertension. Arch Mal Cocur Vaiss 90:1059-1063, 1997
15. Munichoodappa C, D'Elia JA, Libertino JA, Gleason RE, Christlieb AR: Renal artery stenosis in hypertensive diabetics. J Urol 121:555-558, 1979
16. Shapiro AP, Perez-Stable E, Moutsos SE: Co-existence of renal arterial hypertension and diabetes mellitus. JAMA 192:813-816, 1965
17. Bruckert E, De Gennes JL, Malbecq W, Baigts F: Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia. Clin Cardiol 18:621-629, 1995
18. Valabhji J, Kong C, Poulter C, Thom SAM, Feher MD, Elkeles RS, Robinson S: Effects of NIDDM and ethnicity on plasma renin activity in hypertensive subjects (Abstract). Diabetologia 41:A338, 1998
19. U.K. Prospective Diabetes Study Group: Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes UKPDS 39. BMJ 317:713-720, 1998